Cargando…
1034. FebriDx use in Immunocompromised Patients in a Real-World Hospital Setting during the second (COVID-19) wave in Italy
BACKGROUND: The diagnosis of acute respiratory infection (ARI) in patients with immunosuppression secondary to disease or medications is often unclear. Symptoms may be absent or blunted, and acute phase reactants, like procalcitonin (PCT) and C-reactive protein (CRP) may not elevate. For these patie...
Autores principales: | Lagi, Filippo, Bartoloni, Alessandro, Suarez-Cuervo, Catalina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690834/ http://dx.doi.org/10.1093/ofid/ofab466.1228 |
Ejemplares similares
-
Use of the FebriDx point-of-care test for the exclusion of SARS-CoV-2 diagnosis in a population with acute respiratory infection during the second (COVID-19) wave in Italy
por: Lagi, Filippo, et al.
Publicado: (2021) -
FebriDx(®): A Rapid Diagnostic Test for Differentiating Bacterial and Viral Aetiologies in Acute Respiratory Infections
por: Shirley, Matt
Publicado: (2019) -
Diagnostic accuracy of the FebriDx host response point-of-care test in patients hospitalised with suspected COVID-19
por: Clark, Tristan W., et al.
Publicado: (2020) -
Diagnostic Accuracy of FebriDx: A Rapid Test to Detect Immune Responses to Viral and Bacterial Upper Respiratory Infections
por: Self, Wesley H., et al.
Publicado: (2017) -
Utility of the FebriDx point‐of‐care test for rapid triage and identification of possible coronavirus disease 2019 (COVID‐19)
por: Karim, Nawazish, et al.
Publicado: (2020)